Pages that link to "Q35893043"

The following pages link to Plasminogen activator inhibitor-1. (Q35893043):

Displaying 28 items.

• Functional structure of the somatomedin B domain of vitronectin (Q24648799) (← links)
• Role of the TMPRSS2-ERG gene fusion in prostate cancer (Q28269156) (← links)
• Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles (Q28394962) (← links)
• The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles (Q28579043) (← links)
• Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers (Q33931418) (← links)
• Plasminogen activator inhibitor‐1 inhibits factor VIIa bound to tissue factor (Q34630452) (← links)
• Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor (Q35071304) (← links)
• Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents (Q35703384) (← links)
• Retracted: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays (Q36269761) (← links)
• Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade (Q36735157) (← links)
• Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects (Q37022573) (← links)
• Therapeutic potential of plasminogen activator inhibitor-1 inhibitors (Q37775818) (← links)
• Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome (Q37852747) (← links)
• Anaplastic lymphoma kinase: activating mechanisms and signaling pathways (Q37971668) (← links)
• Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present). (Q38092174) (← links)
• Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. (Q39315148) (← links)
• An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease (Q39502058) (← links)
• Inhibition of plasminogen activator inhibitor-1 release from human endothelial cells by Angelica keiskei Koidzumi (Ashitaba) chalcones is structure-dependent (Q42135578) (← links)
• Replacing White Rice with Pre-Germinated Brown Rice Mildly Ameliorates Hyperglycemia and Imbalance of Adipocytokine Levels in Type 2 Diabetes Model Rats (Q42758456) (← links)
• Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism (Q46699154) (← links)
• The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer's Disease. (Q46817822) (← links)
• Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study (Q46988821) (← links)
• Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes (Q47423928) (← links)
• Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits. (Q50241255) (← links)
• Toxicological biomarkers of 2,3,4,7,8-pentachlorodibenzofuran in proteins secreted by HepG2 cells (Q54531630) (← links)
• Plasminogen activator inhibitor-1 polymorphisms (−844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables (Q58052078) (← links)
• The −844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis (Q58052205) (← links)
• FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis (Q92370080) (← links)